Reply to Talarico et al.'s comment: "Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (TNF)-alpha antagonist: a prospective observational study"

Affiliations

¹ Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France. Electronic address: che.helene@yahoo.fr.
² Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France.

Comment

Helene Che et al. Joint Bone Spine. 2014 Jul.

. 2014 Jul;81(4):379-80.

doi: 10.1016/j.jbspin.2014.04.003. Epub 2014 Jun 21.

¹ Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France. Electronic address: che.helene@yahoo.fr.
² Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France.

No abstract available

Keywords: Anti-TNF alpha therapy; Infections; Rheumatoid arthritis.

Comment on

Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis.
Che H, Lukas C, Morel J, Combe B. Che H, et al. Joint Bone Spine. 2014 May;81(3):215-21. doi: 10.1016/j.jbspin.2013.07.009. Epub 2013 Aug 7. Joint Bone Spine. 2014. PMID: 23932722
Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (TNF)-alpha antagonist: a prospective observational study.
Talarico R, Stagnaro C, Ferrari C, Pepe P, Bazzichi L, Bombardieri S. Talarico R, et al. Joint Bone Spine. 2014 Jul;81(4):378-9. doi: 10.1016/j.jbspin.2014.03.020. Epub 2014 Jun 21. Joint Bone Spine. 2014. PMID: 24962976 No abstract available.